⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11293034 | 0.63 | — | — | |
| SCHEMBL1891341 | 0.60 | — | — | |
| SCHEMBL25897323 | 0.57 | — | — | |
| SCHEMBL25897324 | 0.57 | — | — | |
| SCHEMBL4337864 | 0.54 | — | — | |
| SCHEMBL17675856 | 0.54 | — | — | |
| SCHEMBL4546674 | 0.54 | — | — | |
| SCHEMBL24868375 | 0.52 | — | — | |
| SCHEMBL17490369 | 0.51 | APLNR (0.35) | — | |
| SCHEMBL19386283 | 0.49 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051329-B2 | Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors | MERCK SHARP & DOHME CORP. (US) | 2015-06-09 | — | — | US | claimed |
| EP-2729468-A2 | TRICYCLIC HETEROCYCLES USEFUL AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2014-05-14 | — | — | EP | claimed |
| US-20140113920-A1 | TRICYCLIC HETEROCYCLES USEFUL AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2014-04-24 | — | — | US | claimed |
| WO-2013006526-A2 | TRICYCLIC HETEROCYCLES USEFUL AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-01-10 | — | — | WO | claimed |
| US-8136974-B2 | Metal coordination compound and light-emitting material containing the same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-03-20 | — | — | US | claimed |
| US-7622578-B2 | Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate | WYETH (US) | 2009-11-24 | — | — | US | claimed |
| US-7410995-B1 | N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders | GPI NIL HOLDINGS INC. (US) | 2008-08-12 | — | — | US | claimed |
| US-7018994-B2 | 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONS | SCHERING AG (DE) | 2006-03-28 | — | — | US | claimed |
| US-6770599-B2 | Tetrazole derivatives | BAYER CROPSCIENCE KK (JP) | 2004-08-03 | — | — | US | claimed |
| US-6677348-B2 | INDUCE CYTOKINE BIOSYNTHESIS; ANTICARCINOGENIC AGENTS, VIRICIDES | 3M INNOVATIVE PROPERTIES COMPANY | 2004-01-13 | — | — | US | claimed |
| US-6238440-B1 | OXIDATION-DYEING HAIR | L'OREAL S.A. (FR) | 2001-05-29 | — | — | US | claimed |
| US-5753661-A | TREATMENT OF NERVOUS SYSTEM, PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS | H. LUNDBECK A/S (DK) | 1998-05-19 | — | — | US | claimed |
| US-4721729-A | Novel carbacyclins, process for the preparation thereof, and their use as medicinal agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-01-26 | — | — | US | claimed |
| US-4657898-A | CARDIOVACULAR AND PSYCHOLOGICAL DISORDERS, ANALGESICS, OR SEDATIVES | WARNER-LAMBERT COMPANY (US) | 1987-04-14 | — | — | US | claimed |
| US-20050182047-A1 | Treatment of demyelinating disorders | EISAI CO., LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| US-20050130979-A1 | 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders | EISAI CO., LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
| US-20040204347-A1 | Treatment of demyelinating disorders | EISAI CO., LTD. (JP) | 2004-10-14 | — | — | US | disclosed |
| EP-1100504-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR USES FOR TREATMENT OF DEMYELINATING DISORDERS | Eisai Co., Ltd. (JP) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000001376-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR USES FOR TREATMENT OF DEMYELINATING DISORDERS | EISAI CO., LTD (JP) | 2000-01-13 | — | — | WO | disclosed |